IL-10 induces a STAT3-dependent autoregulatory loop in TH2 cells that promotes Blimp-1 restriction of cell expansion via antagonism of STAT5 target genes

Science Immunology

Volumn 1, Issue 5, 2016, Pages

  Poholek, Amanda C ^a,b   Jankovic, Dragana ^c   Villarino, Alejandro V ^a   Petermann, Franziska ^a   Hettinga, Angela ^b   Shouval, Dror S ^d,e   Snapper, Scott B ^d,e   Kaech, Susan M ^f   Brooks, Stephen R ^a   Vahedi, Golnaz ^a,g   Sher, Alan ^c   Kanno, Yuka ^a   O’Shea, John J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85016317149     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aaf8612     Document Type: Article

References (41)

1. E. K. Bikoff, M. A. Morgan, E. J. Robertson, An expanding job description for Blimp-1/ PRDM1. Curr. Opin. Genet. Dev. 19, 379–385 (2009).
2. S. Crotty, R. J. Johnston, S. P. Schoenberger, Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat. Immunol. 11, 114–120 (2010).
3. S. L. Nutt, N. Taubenheim, J. Hasbold, L. M. Corcoran, P. D. Hodgkin, The genetic network controlling plasma cell differentiation. Semin. Immunol. 23, 341–349 (2011).
4. + T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296–308 (2009).
5. E. Cretney, A. Xin, W. Shi, M. Minnich, F. Masson, M. Miasari, G. T. Belz, G. K. Smyth, M. Busslinger, S. L. Nutt, A. Kallies, The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304–311 (2011).
6. A. Ballesteros-Tato, B. León, B. A. Graf, A. Moquin, P. S. Adams, F. E. Lund, T. D. Randall, Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847–856 (2012).
7. FH cell differentiation. J. Exp. Med. 209, 243–250 (2012).
8. C. Neumann, F. Heinrich, K. Neumann, V. Junghans, M.-F. Mashreghi, J. Ahlers, M. Janke, C. Rudolph, N. Mockel-Tenbrinck, A. A. Kühl, M. M. Heimesaat, C. Esser, S.-H. Im, A. Radbruch, S. Rutz, A. Scheffold, Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med. 211, 1807–1819 (2014).
9. R. Jain, Y. Chen, Y. Kanno, B. Joyce-Shaikh, G. Vahedi, K. Hirahara, W. M. Blumenschein, S. Sukumar, C. J. Haines, S. Sadekova, T. K. McClanahan, M. J. McGeachy, J. J. O’Shea, D. J. Cua, Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44, 131–142 (2016).
10. + T cell exhaustion during chronic viral infection. Immunity 31, 309–320 (2009).
11. + T cells and memory responses. Immunity 31, 283–295 (2009).
12. A. Kallies, E. D. Hawkins, G. T. Belz, D. Metcalf, M. Hommel, L. M. Corcoran, P. D. Hodgkin, S. L. Nutt, Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 7, 466–474 (2006).
13. G. A. Martins, L. Cimmino, M. Shapiro-Shelef, M. Szabolcs, A. Herron, E. Magnusdottir, K. Calame, Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat. Immunol. 7, 457–465 (2006).
14. C. A. Anderson, G. Boucher, C. W. Lees, A. Franke, M. D’Amato, K. D. Taylor, J. C. Lee, P. Goyette, M. Imielinski, A. Latiano, C. Lagacé, R. Scott, L. Amininejad, S. Bumpstead, L. Baidoo, R. N. Baldassano, M. Barclay, T. M. Bayless, S. Brand, C. Büning, J.-F. Colombel, L. A. Denson, M. De Vos, M. Dubinsky, C. Edwards, D. Ellinghaus, R. S. N. Fehrmann, J. A. B. Floyd, T. Florin, D. Franchimont, L. Franke, M. Georges, J. Glas, N. L. Glazer, S. L. Guthery, T. Haritunians, N. K. Hayward, J.-P. Hugot, G. Jobin, D. Laukens, I. Lawrance, M. Lémann, A. Levine, C. Libioulle, E. Louis, D. P. McGovern, M. Milla, G. W. Montgomery, K. I. Morley, C. Mowat, A. Ng, W. Newman, R. A. Ophoff, L. Papi, O. Palmieri, L. Peyrin-Biroulet, J. Panés, A. Phillips, N. J. Prescott, D. D. Proctor, R. Roberts, R. Russell, P. Rutgeerts, J. Sanderson, M. Sans, P. Schumm, F. Seibold, Y. Sharma, L. A. Simms, M. Seielstad, A. H. Steinhart, S. R. Targan, L. H. van den Berg, M. Vatn, H. Verspaget, T. Walters, C. Wijmenga, D. C. Wilson, H.-J. Westra, R. J. Xavier, Z. Z. Zhao, C. Y. Ponsioen, V. Andersen, L. Torkvist, M. Gazouli, N. P. Anagnou, T. H. Karlsen, L. Kupcinskas, J. Sventoraityte, J. C. Mansfield, S. Kugathasan, M. S. Silverberg, J. Halfvarson, J. I. Rotter, C. G. Mathew, A. M. Griffiths, R. Gearry, T. Ahmad, S. R. Brant, M. Chamaillard, J. Satsangi, J. H. Cho, S. Schreiber, M. J. Daly, J. C. Barrett, M. Parkes, V. Annese, H. Hakonarson, G. Radford-Smith, R. H. Duerr, S. Vermeire, R. K. Weersma, J. D. Rioux, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246–252 (2011).
15. D. Ellinghaus, H. Zhang, S. Zeissig, S. Lipinski, A. Till, T. Jiang, B. Stade, Y. Bromberg, E. Ellinghaus, A. Keller, M. A. Rivas, J. Skieceviciene, N. T. Doncheva, X. Liu, Q. Liu, F. Jiang, M. Forster, G. Mayr, M. Albrecht, R. Häsler, B. O. Boehm, J. Goodall, C. R. Berzuini, J. Lee, V. Andersen, U. Vogel, L. Kupcinskas, M. Kayser, M. Krawczak, S. Nikolaus, R. K. Weersma, C. Y. Ponsioen, M. Sans, C. Wijmenga, D. P. Strachan, W. L. McArdle, S. Vermeire, P. Rutgeerts, J. D. Sanderson, C. G. Mathew, M. H. Vatn, J. Wang, M. M. Nöthen, R. H. Duerr, C. Büning, S. Brand, J. Glas, J. Winkelmann, T. Illig, A. Latiano, V. Annese, J. Halfvarson, M. D’Amato, M. J. Daly, M. Nothnagel, T. H. Karlsen, S. Subramani, P. Rosenstiel, S. Schreiber, M. Parkes, A. Franke, Association between variants of PRDM1 and NDP52 and Crohn’s disease, based on exome sequencing and functional studies. Gastroenterology 145, 339–347 (2013).
16. V. Gateva, J. K. Sandling, G. Hom, K. E. Taylor, S. A. Chung, X. Sun, W. Ortmann, R. Kosoy, R. C. Ferreira, G. Nordmark, I. Gunnarsson, E. Svenungsson, L. Padyukov, G. Sturfelt, A. Jönsen, A. A. Bengtsson, S. Rantapää-Dahlqvist, E. C. Baechler, E. E. Brown, G. S. Alarcón, J. C. Edberg, R. Ramsey-Goldman, G. McGwin Jr., J. D. Reveille, L. M. Vilá, R. P. Kimberly, S. Manzi, M. A. Petri, A. Lee, P. K. Gregersen, M. F. Seldin, L. Rönnblom, L. A. Criswell, A.-C. Syvänen, T. W. Behrens, R. R. Graham, A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228–1233 (2009).
17. S. Raychaudhuri, B. P. Thomson, E. F. Remmers, S. Eyre, A. Hinks, C. Guiducci, J. J. Catanese, G. Xie, E. A. Stahl, R. Chen, L. Alfredsson, C. I. Amos, K. G. Ardlie; BIRAC Consortium, A. Barton, J. Bowes, N. P. Burtt, M. Chang, J. Coblyn, K. H. Costenbader, L. A. Criswell, J. B. A. Crusius, J. Cui, P. L. De Jager, B. Ding, P. Emery, E. Flynn, P. Harrison, L. J. Hocking, T. W. J. Huizinga, D. L. Kastner, X. Ke, F. A. S. Kurreeman, A. T. Lee, X. Liu, Y. Li, P. Martin, A. W. Morgan, L. Padyukov, D. M. Reid, M. Seielstad, M. F. Seldin, N. A. Shadick, S. Steer, P. P. Tak, W. Thomson, A. H. M. van der Helm-van Mil, I. E. van der Horst-Bruinsma, M. E. Weinblatt, A. G. Wilson, G. J. Wolbink, P. Wordsworth; YEAR Consortium, D. Altshuler, E. W. Karlson, R. E. M. Toes, N. de Vries, A. B. Begovich, K. A. Siminovitch, J. Worthington, L. Klareskog, P. K. Gregersen, M. J. Daly, R. M. Plenge, Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41, 1313–1318 (2009).
18. X.-J. Zhou, X.-L. Lu, J.-C. Lv, H.-Z. Yang, L.-X. Qin, M.-H. Zhao, Y. Su, Z.-G. Li, H. Zhang, Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann. Rheum. Dis. 70, 1330–1337 (2011).
19. A. S. Weinmann, Regulatory mechanisms that control T-follicular helper and T-helper 1 cell flexibility. Immunol. Cell Biol. 92, 34–39 (2014).
20. + T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 238, 247–262 (2010).
21. G. A. Martins, L. Cimmino, J. Liao, E. Magnusdottir, K. Calame, Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J. Exp. Med. 205, 1959–1965 (2008).
22. D. Gong, T. R. Malek, Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J. Immunol. 178, 242–252 (2007).
23. G. L. Stritesky, R. Muthukrishnan, S. Sehra, R. Goswami, D. Pham, J. Travers, E. T. Nguyen, D. E. Levy, M. H. Kaplan, The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34, 39–49 (2011).
24. T. A. Wynn, I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, A. Sher, Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151, 1430–1440 (1993).
25. A. T. Vella, E. J. Pearce, CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148, 2283–2290 (1992).
26. T. R. Mosmann, J. H. Schumacher, D. F. Fiorentino, J. Leverah, K. W. Moore, M. W. Bond, Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145, 2938–2945 (1990).
27. R. M. Weber-Nordt, J. K. Riley, A. C. Greenlund, K. W. Moore, J. E. Darnell, R. D. Schreiber, Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 271, 27954–27961 (1996).
28. J. Wehinger, F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann, R. M. Weber-Nordt, IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394, 365–370 (1996).
29. J. S. Stumhofer, J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. M. Saris, J. J. O’Shea, C. A. Hunter, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363–1371 (2007).
30. M. Minnich, H. Tagoh, P. Bönelt, E. Axelsson, M. Fischer, B. Cebolla, A. Tarakhovsky, S. L. Nutt, M. Jaritz, M. Busslinger, Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation. Nat. Immunol. 17, 331–343 (2016).
31. D. S. Shouval, J. Ouahed, A. Biswas, J. A. Goettel, B. H. Horwitz, C. Klein, A. M. Muise, S. B. Snapper, Interleukin 10 receptor signaling: Master regulator of intestinal mucosal homeostasis in mice and humans. Adv. Immunol. 122, 177–210 (2014).
32. Q. Jiang, W. Q. Li, F. B. Aiello, R. Mazzucchelli, B. Asefa, A. R. Khaled, S. K. Durum, Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16, 513–533 (2005).
33. A. Villarino, A. Laurence, G. W. Robinson, M. Bonelli, B. Dema, B. Afzali, H.-Y. Shih, H.-W. Sun, S. R. Brooks, L. Hennighausen, Y. Kanno, J. J. O’Shea, Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. eLife 5, e08384 (2016).
34. D. Eto, C. Lao, D. DiToro, B. Barnett, T. C. Escobar, R. Kageyama, I. Yusuf, S. Crotty, IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLOS ONE 6, e17739 (2011).
35. J. P. Ray, H. D. Marshall, B. J. Laidlaw, M. M. Staron, S. M. Kaech, J. Craft, Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 40, 367–377 (2014).
36. C.-K. Lee, R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho, D. E. Levy, STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63–72 (2002).
37. J. E. Durbin, R. Hackenmiller, M. C. Simon, D. E. Levy, Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443–450 (1996).
38. X.-P. Yang, K. Ghoreschi, S. M. Steward-Tharp, J. Rodriguez-Canales, J. Zhu, J. R. Grainger, K. Hirahara, H.-W. Sun, L. Wei, G. Vahedi, Y. Kanno, J. J. O’Shea, A. Laurence, Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247–254 (2011).
39. M. Onishi, T. Nosaka, K. Misawa, A. L.-F. Mui, D. Gorman, M. McMahon, A. Miyajima, T. Kitamura, Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871–3879 (1998).
40. W. Liao, R. Spolski, P. Li, N. Du, E. E. West, M. Ren, S. Mitra, W. J. Leonard, Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc. Natl. Acad. Sci. U.S.A. 111, 3508–3513 (2014).
41. G. Vahedi, H. Takahashi, S. Nakayamada, H.-W. Sun, V. Sartorelli, Y. Kanno, J. J. O’Shea, STATs shape the active enhancer landscape of T cell populations. Cell 151, 981–993 (2012).